Teva Set To Be Fined By EU Antitrust Regulators In Coming Weeks For Disparaging Rival Multiple Sclerosis Medicine
Teva Set To Be Fined By EU Antitrust Regulators In Coming Weeks For Disparaging Rival Multiple Sclerosis Medicine
Teva將在未來幾周被歐盟反壟斷監管機構處以罰款，因貶低競爭對手的多發性硬化症藥物
Teva Set To Be Fined By EU Antitrust Regulators In Coming Weeks For Disparaging Rival Multiple Sclerosis Medicine
Teva將在未來幾周內因貶低競爭對手多發性硬化症藥物而被歐盟反壟斷監管機構罰款
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間